Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Lucas

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514William G Kraybill, Jonathon Harris, Ira J Spiro, et al.
Histopathology|September 14, 2022
PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysisSteven M Hrycaj, Julianne M Szczepanski, Lili Zhao, et al.
Cancer|June 24, 2010
Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514William G Kraybill, Jonathan Harris, Ira J Spiro, et al.
Archives of Pathology & Laboratory Medicine|September 3, 2013
Funding anatomic pathology research: a retrospective analysis of an intramural funding mechanismAndrew McDaniel, Douglas R Fullen, Kathleen R Cho, et al.
Human Pathology|September 25, 2016
Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p lossLorena Lazo de la Vega, Daniel H Hovelson, Andi K Cani, et al.
Radiology|April 12, 2022
Ultrasonography of Superficial Soft-Tissue Masses: Society of Radiologists in Ultrasound Consensus Conference StatementJon A Jacobson, William D Middleton, Sandra J Allison, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2014
CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expressionSteven Christopher Smith, Darya Buehler, Eun-Young Karen Choi, et al.
The American Journal of Surgical Pathology|September 7, 2017
Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic StudySteven C Smith, William E Gooding, Matthew Elkins, et al.
Human Pathology|October 29, 2017
The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromesAaron M Udager, Martin J Magers, Dayna M Goerke, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2015
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcomaElizabeth J Davis, Rashmi Chugh, Lili Zhao, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514William G Kraybill, Jonathon Harris, Ira J Spiro, et al.
Histopathology|September 14, 2022
PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysisSteven M Hrycaj, Julianne M Szczepanski, Lili Zhao, et al.
Cancer|June 24, 2010
Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514William G Kraybill, Jonathan Harris, Ira J Spiro, et al.
Archives of Pathology & Laboratory Medicine|September 3, 2013
Funding anatomic pathology research: a retrospective analysis of an intramural funding mechanismAndrew McDaniel, Douglas R Fullen, Kathleen R Cho, et al.
Human Pathology|September 25, 2016
Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p lossLorena Lazo de la Vega, Daniel H Hovelson, Andi K Cani, et al.
Radiology|April 12, 2022
Ultrasonography of Superficial Soft-Tissue Masses: Society of Radiologists in Ultrasound Consensus Conference StatementJon A Jacobson, William D Middleton, Sandra J Allison, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2014
CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expressionSteven Christopher Smith, Darya Buehler, Eun-Young Karen Choi, et al.
The American Journal of Surgical Pathology|September 7, 2017
Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic StudySteven C Smith, William E Gooding, Matthew Elkins, et al.
Human Pathology|October 29, 2017
The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromesAaron M Udager, Martin J Magers, Dayna M Goerke, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2015
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcomaElizabeth J Davis, Rashmi Chugh, Lili Zhao, et al.
Pageof 9